Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-08

FDA Approved: L-GLUTAMINE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' original ANDA for L-Glutamine, authorizing a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-GLUTAMINE (L-Glutamine)

Snippet

ORIG AP for L-GLUTAMINE (L-GLUTAMINE)